D2M Biotherapeutics United States

A human-genetics driven next generation immunity-oncology company
Nan Bing
CEO 
Functionality

D3 BIO

Website:
www.d3bio.com
Partnering Objectives
Biotech/Pharma Category
Dr John Jin
Dr John Jin
Co-founder & CBO 
Functionality
John Jin
Co-founder&CBO 

dalton venture China

专注医疗投资
Website:
daltonventure.cn
Partnering Objectives
Headquartner in China
yan zhang
investment director 

Dao Tun GmbH Switzerland

Dao Tun is a consulting company, founded in 2019, specialised in cross-border collaboration between Europe and China, primarily in the healthcare and life science industry.
Dao Tun is based in the Basel region, one of the world's leading clusters for Pharma and Life Sciences and also part of the trinational Biovalley region (Switzerland, Germany, France).
Dao Tun team provides customised strategy and execution plan via in-depth interview and targeted research; quickly gains insights into the association and matching between potential partners to make accurate and effective connections; simplifies the processes, reduces the cost of communication, and establishes the trust with full care.
Dao Tun is a bridge builder who excels at understanding and interpreting their interests and needs, and aligning perspectives of different stakeholders and across cultures for win-win-win situation.

Dr. Tianke Wang
Dr. Tianke Wang
CEO 
Functionality

Dawn Biopharmaceuticals Inc. United States

Dawn Biopharmaceuticals Inc (DBI) is a US firm founded by Gordon Lee, MD (UK MBChB), MBA (Wharton) who has access to a proprietary cell-based immunotherapeutic product for clinical development in the US. The product is a multivalent cancer therapy that integrates multiple anti-cancer mechanisms in one modifiable platform. The product is tumor-homing, disables the local tumor defenses and expresses a therapeutic cytokine in the cancer - but not systemically.

(Please note that the website is pending.)
Website:
dawnbio.net
Company Size (Fulltime employees)
Year of foundation
2020
Headquartner in China
Assets Information 1
Initial round
Gordon Lee
Founder 
Functionality

DCHealth Inc United States

Oncology Big Data company headquartered in Beijing. Chinese name 神州医疗 or Digital Health China. US branch in Boston.
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
Fan Zhang
Director of BD 

Debn

Prostate biopsy needle with antibiotic coating .
Website:
Denbn.eu
Company Size (Fulltime employees)
Year of foundation
2017
Partnering Objectives
Please specify your partnering goal
Funding
Headquartner in China
Medtech Information 1
Drug eluting biopsy needle|biopsy needle realase active layer during biopsy procedure preventing from infections following biopsy procedure|Usa.europe
Medtech Development Stage
Mr. Michal Kruzycki
Ceo 
Functionality

Device of tomorrow capital llc United States

US dollar fund,focusing on medical device and Medtech area.
Partnering Objectives
Headquartner in China
Yan Henry
Managing partner 

DHVC United States

Life Science and Healthcare Venture Capital Investor
Website:
www.dh.vc
Company Size (Fulltime employees)
Year of foundation
2013
Partnering Objectives
Please specify your partnering goal
Investment
Headquartner in China
Medtech Development Stage
Ali Farahanchi
Managing Director 
Functionality

dizal pharmaceutical China

biotech focusing on world leading r&d to solve unmet medical needs
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
Mei Wang
team leader